Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.89% |
| 2 | Consumer Discretionary | 1.29% |
| 3 | Communication Services | 0.93% |
| 4 | Healthcare | 0.89% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
Royal Caribbean
RCL
$78.1B
| $296M | 0.04% |
3,331,100
+366,500
| +12% | +$29.6M |
|
377
CALL
Bristol-Myers Squibb
BMY
$137B
| $295M | 0.04% |
4,982,600
-524,600
| -10% | -$34.5M |
|
378
CALL
Merck
MRK
$376B
| $293M | 0.04% |
3,906,100
-1,869,100
| -32% | -$142M |
|
379
CALL
PepsiCo
PEP
$196B
| $293M | 0.04% |
1,950,200
-523,000
| -21% | -$81M |
|
380
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $293M | 0.04% |
7,815,800
-17,257,600
| -69% | -$646M |
|
381
CALL
DexCom
DXCM
$34.8B
| $293M | 0.04% |
2,144,000
-534,400
| -20% | -$67.4M |
|
382
CALL
Biogen
BIIB
$32B
| $292M | 0.04% |
1,033,300
-80,700
| -7% | -$26.4M |
|
383
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
| $292M | 0.04% |
3,254,400
+1,469,200
| +82% | +$133M |
|
|
384
PUT
Bristol-Myers Squibb
BMY
$137B
| $292M | 0.04% |
4,926,700
+2,426,000
| +97% | +$160M |
|
385
Alibaba
BABA
$286B
| $291M | 0.04% |
1,968,375
-552,314
| -22% | -$100M |
|
386
CALL
Pinterest
PINS
$13.3B
| $291M | 0.04% |
5,712,300
+722,700
| +14% | +$44.4M |
|
387
CALL
Cleveland-Cliffs
CLF
$6.43B
| $291M | 0.04% |
14,669,200
+2,187,100
| +18% | +$49.8M |
|
388
PUT
Carvana
CVNA
$76.9B
| $289M | 0.04% |
4,797,500
+2,242,000
| +88% | +$149M |
|
389
Costco
COST
$420B
| $289M | 0.04% |
643,240
+128,427
| +25% | +$56.5M |
|
390
CALL
Enphase Energy
ENPH
$5.1B
| $287M | 0.04% |
1,914,200
-637,600
| -25% | -$109M |
|
391
CALL
Honeywell
HON
$68.4B
| $287M | 0.04% |
1,432,987
+275,754
| +24% | +$58.8M |
|
|
COUP
392
CALL
DELISTED
Coupa Software Incorporated
COUP
| $287M | 0.04% |
1,307,200
+83,600
| +7% | +$19.6M |
|
393
Novavax
NVAX
$1.47B
| $284M | 0.04% |
1,371,154
+700,509
| +104% | +$154M |
|
394
CALL
Eli Lilly
LLY
$1.12T
| $283M | 0.04% |
1,225,400
-759,400
| -38% | -$187M |
|
395
PUT
Analog Devices
ADI
$182B
| $283M | 0.04% |
1,688,800
+1,324,000
| +363% | +$222M |
|
396
PUT
Alcoa
AA
$13.7B
| $281M | 0.04% |
5,751,600
-421,000
| -7% | -$17.8M |
|
397
Gilead Sciences
GILD
$181B
| $280M | 0.04% |
4,003,703
+522,678
| +15% | +$36.7M |
|
398
CALL
Simon Property Group
SPG
$70.6B
| $278M | 0.04% |
2,141,900
+149,700
| +8% | +$19.5M |
|
399
PUT
Texas Instruments
TXN
$241B
| $275M | 0.04% |
1,431,800
-583,000
| -29% | -$111M |
|
400
PUT
Humana
HUM
$45.5B
| $275M | 0.04% |
705,500
+400
| +0.1% | +$170K |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.
By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,560 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.